The global BCG Vaccine for Tuberculosis (TB) Market growth is projected to reach US$ 80.8 million in 2025 to US$ 97 million in 2031; it is expected to grow at a CAGR of 3.2% from 2025 to 2031.

Global BCG Vaccine for Tuberculosis (TB) Market Growth And Outlook 2025-31

The global BCG Vaccine for Tuberculosis (TB) market size is predicted to grow from US$ 80.8 million in 2025 to US$ 97 million in 2031; it is expected to grow at a CAGR of 3.2% from 2025 to 2031. BCG Vaccine for Tuberculosis (TB) provides immunity or protection against tuberculosis (TB). The vaccine may be given to persons at high risk of developing TB. Key driver for the BCG vaccine market is the increasing prevalence of tuberculosis (TB) in various regions, especially in countries with lower healthcare resources. Rising TB cases have driven governments and global health organizations, like the World Health Organization (WHO), to actively promote TB vaccination programs to curb the spread of the disease. Efforts to increase BCG vaccine coverage in high-risk areas and the focus on reducing childhood TB have further propelled demand, creating a sustained need for vaccine supply and development. A major challenge in the BCG vaccine market is the variability in its effectiveness, especially against pulmonary TB in adults. This inconsistency in protection levels has led to cautious adoption in some regions with lower TB rates. Moreover, the emergence of multi-drug-resistant TB strains complicates the market, as BCG is not effective against these resistant strains. These limitations emphasize the need for alternative vaccines or treatments, affecting the long-term outlook for BCG as a standalone solution in TB prevention. Infinity Market Research newest research report, the ?BCG Vaccine for Tuberculosis (TB) Industry Forecast? looks at past sales and reviews total world BCG Vaccine for Tuberculosis (TB) sales in 2024, providing a comprehensive analysis by region and market sector of projected BCG Vaccine for Tuberculosis (TB) sales for 2025 through 2031. With BCG Vaccine for Tuberculosis (TB) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world BCG Vaccine for Tuberculosis (TB) industry. This Insight Report provides a comprehensive analysis of the global BCG Vaccine for Tuberculosis (TB) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on BCG Vaccine for Tuberculosis (TB) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global BCG Vaccine for Tuberculosis (TB) market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for BCG Vaccine for Tuberculosis (TB) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global BCG Vaccine for Tuberculosis (TB). This report presents a comprehensive overview, market shares, and growth opportunities of BCG Vaccine for Tuberculosis (TB) market by product type, application, key manufacturers and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; Immune Type &nbsp;&nbsp;&nbsp; Therapy Type Segmentation by Application: &nbsp;&nbsp;&nbsp; Hospitals &nbsp;&nbsp;&nbsp; Clinics &nbsp;&nbsp;&nbsp; Others This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; Merck &nbsp;&nbsp;&nbsp; Japan BCG Lab &nbsp;&nbsp;&nbsp; China National Biotec &nbsp;&nbsp;&nbsp; AJ Vaccines &nbsp;&nbsp;&nbsp; Serum Institute of India &nbsp;&nbsp;&nbsp; BioFarma &nbsp;&nbsp;&nbsp; GSBPL &nbsp;&nbsp;&nbsp; Biomed Lublin &nbsp;&nbsp;&nbsp; Taj Pharmaceuticals &nbsp;&nbsp;&nbsp; Ataulpho de Paiva &nbsp;&nbsp;&nbsp; ANLIS Malbran &nbsp;&nbsp;&nbsp; Funda?o Ataulpho de Paiva &nbsp;&nbsp;&nbsp; BB-NCIPD &nbsp;&nbsp;&nbsp; Torlakinstitut &nbsp;&nbsp;&nbsp; IVAC?InstituteofVaccinesandMedicalBiologicals &nbsp;&nbsp;&nbsp; Institut Pasteur de Tunis Key Questions Addressed in this Report What is the 10-year outlook for the global BCG Vaccine for Tuberculosis (TB) market? What factors are driving BCG Vaccine for Tuberculosis (TB) market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do BCG Vaccine for Tuberculosis (TB) market opportunities vary by end market size? How does BCG Vaccine for Tuberculosis (TB) break out by Type, by Application?

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global BCG Vaccine for Tuberculosis (TB) Annual Sales 2020-2031 &nbsp;2.1.2 World Current & Future Analysis for BCG Vaccine for Tuberculosis (TB) by Geographic Region, 2020, 2024 & 2031 &nbsp;2.1.3 World Current & Future Analysis for BCG Vaccine for Tuberculosis (TB) by Country/Region, 2020, 2024 & 2031 &nbsp;2.2 BCG Vaccine for Tuberculosis (TB) Segment by Type &nbsp;2.2.1 Immune Type &nbsp;2.2.2 Therapy Type &nbsp;2.3 BCG Vaccine for Tuberculosis (TB) Sales by Type &nbsp;2.3.1 Global BCG Vaccine for Tuberculosis (TB) Sales Market Share by Type (2020-2025) &nbsp;2.3.2 Global BCG Vaccine for Tuberculosis (TB) Revenue and Market Share by Type (2020-2025) &nbsp;2.3.3 Global BCG Vaccine for Tuberculosis (TB) Sale Price by Type (2020-2025) &nbsp;2.4 BCG Vaccine for Tuberculosis (TB) Segment by Application &nbsp;2.4.1 Hospitals &nbsp;2.4.2 Clinics &nbsp;2.4.3 Others &nbsp;2.5 BCG Vaccine for Tuberculosis (TB) Sales by Application &nbsp;2.5.1 Global BCG Vaccine for Tuberculosis (TB) Sale Market Share by Application (2020-2025) &nbsp;2.5.2 Global BCG Vaccine for Tuberculosis (TB) Revenue and Market Share by Application (2020-2025) &nbsp;2.5.3 Global BCG Vaccine for Tuberculosis (TB) Sale Price by Application (2020-2025) 3 Global by Company &nbsp;3.1 Global BCG Vaccine for Tuberculosis (TB) Breakdown Data by Company &nbsp;3.1.1 Global BCG Vaccine for Tuberculosis (TB) Annual Sales by Company (2020-2025) &nbsp;3.1.2 Global BCG Vaccine for Tuberculosis (TB) Sales Market Share by Company (2020-2025) &nbsp;3.2 Global BCG Vaccine for Tuberculosis (TB) Annual Revenue by Company (2020-2025) &nbsp;3.2.1 Global BCG Vaccine for Tuberculosis (TB) Revenue by Company (2020-2025) &nbsp;3.2.2 Global BCG Vaccine for Tuberculosis (TB) Revenue Market Share by Company (2020-2025) &nbsp;3.3 Global BCG Vaccine for Tuberculosis (TB) Sale Price by Company &nbsp;3.4 Key Manufacturers BCG Vaccine for Tuberculosis (TB) Producing Area Distribution, Sales Area, Product Type &nbsp;3.4.1 Key Manufacturers BCG Vaccine for Tuberculosis (TB) Product Location Distribution &nbsp;3.4.2 Players BCG Vaccine for Tuberculosis (TB) Products Offered &nbsp;3.5 Market Concentration Rate Analysis &nbsp;3.5.1 Competition Landscape Analysis &nbsp;3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) &nbsp;3.6 New Products and Potential Entrants &nbsp;3.7 Market M&A Activity & Strategy 4 World Historic Review for BCG Vaccine for Tuberculosis (TB) by Geographic Region &nbsp;4.1 World Historic BCG Vaccine for Tuberculosis (TB) Market Size by Geographic Region (2020-2025) &nbsp;4.1.1 Global BCG Vaccine for Tuberculosis (TB) Annual Sales by Geographic Region (2020-2025) &nbsp;4.1.2 Global BCG Vaccine for Tuberculosis (TB) Annual Revenue by Geographic Region (2020-2025) &nbsp;4.2 World Historic BCG Vaccine for Tuberculosis (TB) Market Size by Country/Region (2020-2025) &nbsp;4.2.1 Global BCG Vaccine for Tuberculosis (TB) Annual Sales by Country/Region (2020-2025) &nbsp;4.2.2 Global BCG Vaccine for Tuberculosis (TB) Annual Revenue by Country/Region (2020-2025) &nbsp;4.3 Americas BCG Vaccine for Tuberculosis (TB) Sales Growth &nbsp;4.4 APAC BCG Vaccine for Tuberculosis (TB) Sales Growth &nbsp;4.5 Europe BCG Vaccine for Tuberculosis (TB) Sales Growth &nbsp;4.6 Middle East & Africa BCG Vaccine for Tuberculosis (TB) Sales Growth 5 Americas &nbsp;5.1 Americas BCG Vaccine for Tuberculosis (TB) Sales by Country &nbsp;5.1.1 Americas BCG Vaccine for Tuberculosis (TB) Sales by Country (2020-2025) &nbsp;5.1.2 Americas BCG Vaccine for Tuberculosis (TB) Revenue by Country (2020-2025) &nbsp;5.2 Americas BCG Vaccine for Tuberculosis (TB) Sales by Type (2020-2025) &nbsp;5.3 Americas BCG Vaccine for Tuberculosis (TB) Sales by Application (2020-2025) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC BCG Vaccine for Tuberculosis (TB) Sales by Region &nbsp;6.1.1 APAC BCG Vaccine for Tuberculosis (TB) Sales by Region (2020-2025) &nbsp;6.1.2 APAC BCG Vaccine for Tuberculosis (TB) Revenue by Region (2020-2025) &nbsp;6.2 APAC BCG Vaccine for Tuberculosis (TB) Sales by Type (2020-2025) &nbsp;6.3 APAC BCG Vaccine for Tuberculosis (TB) Sales by Application (2020-2025) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia &nbsp;6.10 China Taiwan 7 Europe &nbsp;7.1 Europe BCG Vaccine for Tuberculosis (TB) by Country &nbsp;7.1.1 Europe BCG Vaccine for Tuberculosis (TB) Sales by Country (2020-2025) &nbsp;7.1.2 Europe BCG Vaccine for Tuberculosis (TB) Revenue by Country (2020-2025) &nbsp;7.2 Europe BCG Vaccine for Tuberculosis (TB) Sales by Type (2020-2025) &nbsp;7.3 Europe BCG Vaccine for Tuberculosis (TB) Sales by Application (2020-2025) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa BCG Vaccine for Tuberculosis (TB) by Country &nbsp;8.1.1 Middle East & Africa BCG Vaccine for Tuberculosis (TB) Sales by Country (2020-2025) &nbsp;8.1.2 Middle East & Africa BCG Vaccine for Tuberculosis (TB) Revenue by Country (2020-2025) &nbsp;8.2 Middle East & Africa BCG Vaccine for Tuberculosis (TB) Sales by Type (2020-2025) &nbsp;8.3 Middle East & Africa BCG Vaccine for Tuberculosis (TB) Sales by Application (2020-2025) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Manufacturing Cost Structure Analysis &nbsp;10.1 Raw Material and Suppliers &nbsp;10.2 Manufacturing Cost Structure Analysis of BCG Vaccine for Tuberculosis (TB) &nbsp;10.3 Manufacturing Process Analysis of BCG Vaccine for Tuberculosis (TB) &nbsp;10.4 Industry Chain Structure of BCG Vaccine for Tuberculosis (TB) 11 Marketing, Distributors and Customer &nbsp;11.1 Sales Channel &nbsp;11.1.1 Direct Channels &nbsp;11.1.2 Indirect Channels &nbsp;11.2 BCG Vaccine for Tuberculosis (TB) Distributors &nbsp;11.3 BCG Vaccine for Tuberculosis (TB) Customer 12 World Forecast Review for BCG Vaccine for Tuberculosis (TB) by Geographic Region &nbsp;12.1 Global BCG Vaccine for Tuberculosis (TB) Market Size Forecast by Region &nbsp;12.1.1 Global BCG Vaccine for Tuberculosis (TB) Forecast by Region (2026-2031) &nbsp;12.1.2 Global BCG Vaccine for Tuberculosis (TB) Annual Revenue Forecast by Region (2026-2031) &nbsp;12.2 Americas Forecast by Country (2026-2031) &nbsp;12.3 APAC Forecast by Region (2026-2031) &nbsp;12.4 Europe Forecast by Country (2026-2031) &nbsp;12.5 Middle East & Africa Forecast by Country (2026-2031) &nbsp;12.6 Global BCG Vaccine for Tuberculosis (TB) Forecast by Type (2026-2031) &nbsp;12.7 Global BCG Vaccine for Tuberculosis (TB) Forecast by Application (2026-2031) 13 Key Players Analysis &nbsp;13.1 Merck &nbsp;13.1.1 Merck Company Information &nbsp;13.1.2 Merck BCG Vaccine for Tuberculosis (TB) Product Portfolios and Specifications &nbsp;13.1.3 Merck BCG Vaccine for Tuberculosis (TB) Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.1.4 Merck Main Business Overview &nbsp;13.1.5 Merck Latest Developments &nbsp;13.2 Japan BCG Lab &nbsp;13.2.1 Japan BCG Lab Company Information &nbsp;13.2.2 Japan BCG Lab BCG Vaccine for Tuberculosis (TB) Product Portfolios and Specifications &nbsp;13.2.3 Japan BCG Lab BCG Vaccine for Tuberculosis (TB) Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.2.4 Japan BCG Lab Main Business Overview &nbsp;13.2.5 Japan BCG Lab Latest Developments &nbsp;13.3 China National Biotec &nbsp;13.3.1 China National Biotec Company Information &nbsp;13.3.2 China National Biotec BCG Vaccine for Tuberculosis (TB) Product Portfolios and Specifications &nbsp;13.3.3 China National Biotec BCG Vaccine for Tuberculosis (TB) Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.3.4 China National Biotec Main Business Overview &nbsp;13.3.5 China National Biotec Latest Developments &nbsp;13.4 AJ Vaccines &nbsp;13.4.1 AJ Vaccines Company Information &nbsp;13.4.2 AJ Vaccines BCG Vaccine for Tuberculosis (TB) Product Portfolios and Specifications &nbsp;13.4.3 AJ Vaccines BCG Vaccine for Tuberculosis (TB) Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.4.4 AJ Vaccines Main Business Overview &nbsp;13.4.5 AJ Vaccines Latest Developments &nbsp;13.5 Serum Institute of India &nbsp;13.5.1 Serum Institute of India Company Information &nbsp;13.5.2 Serum Institute of India BCG Vaccine for Tuberculosis (TB) Product Portfolios and Specifications &nbsp;13.5.3 Serum Institute of India BCG Vaccine for Tuberculosis (TB) Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.5.4 Serum Institute of India Main Business Overview &nbsp;13.5.5 Serum Institute of India Latest Developments &nbsp;13.6 BioFarma &nbsp;13.6.1 BioFarma Company Information &nbsp;13.6.2 BioFarma BCG Vaccine for Tuberculosis (TB) Product Portfolios and Specifications &nbsp;13.6.3 BioFarma BCG Vaccine for Tuberculosis (TB) Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.6.4 BioFarma Main Business Overview &nbsp;13.6.5 BioFarma Latest Developments &nbsp;13.7 GSBPL &nbsp;13.7.1 GSBPL Company Information &nbsp;13.7.2 GSBPL BCG Vaccine for Tuberculosis (TB) Product Portfolios and Specifications &nbsp;13.7.3 GSBPL BCG Vaccine for Tuberculosis (TB) Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.7.4 GSBPL Main Business Overview &nbsp;13.7.5 GSBPL Latest Developments &nbsp;13.8 Biomed Lublin &nbsp;13.8.1 Biomed Lublin Company Information &nbsp;13.8.2 Biomed Lublin BCG Vaccine for Tuberculosis (TB) Product Portfolios and Specifications &nbsp;13.8.3 Biomed Lublin BCG Vaccine for Tuberculosis (TB) Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.8.4 Biomed Lublin Main Business Overview &nbsp;13.8.5 Biomed Lublin Latest Developments &nbsp;13.9 Taj Pharmaceuticals &nbsp;13.9.1 Taj Pharmaceuticals Company Information &nbsp;13.9.2 Taj Pharmaceuticals BCG Vaccine for Tuberculosis (TB) Product Portfolios and Specifications &nbsp;13.9.3 Taj Pharmaceuticals BCG Vaccine for Tuberculosis (TB) Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.9.4 Taj Pharmaceuticals Main Business Overview &nbsp;13.9.5 Taj Pharmaceuticals Latest Developments &nbsp;13.10 Ataulpho de Paiva &nbsp;13.10.1 Ataulpho de Paiva Company Information &nbsp;13.10.2 Ataulpho de Paiva BCG Vaccine for Tuberculosis (TB) Product Portfolios and Specifications &nbsp;13.10.3 Ataulpho de Paiva BCG Vaccine for Tuberculosis (TB) Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.10.4 Ataulpho de Paiva Main Business Overview &nbsp;13.10.5 Ataulpho de Paiva Latest Developments &nbsp;13.11 ANLIS Malbran &nbsp;13.11.1 ANLIS Malbran Company Information &nbsp;13.11.2 ANLIS Malbran BCG Vaccine for Tuberculosis (TB) Product Portfolios and Specifications &nbsp;13.11.3 ANLIS Malbran BCG Vaccine for Tuberculosis (TB) Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.11.4 ANLIS Malbran Main Business Overview &nbsp;13.11.5 ANLIS Malbran Latest Developments &nbsp;13.12 Funda�?o Ataulpho de Paiva &nbsp;13.12.1 Funda�?o Ataulpho de Paiva Company Information &nbsp;13.12.2 Funda�?o Ataulpho de Paiva BCG Vaccine for Tuberculosis (TB) Product Portfolios and Specifications &nbsp;13.12.3 Funda�?o Ataulpho de Paiva BCG Vaccine for Tuberculosis (TB) Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.12.4 Funda�?o Ataulpho de Paiva Main Business Overview &nbsp;13.12.5 Funda�?o Ataulpho de Paiva Latest Developments &nbsp;13.13 BB-NCIPD &nbsp;13.13.1 BB-NCIPD Company Information &nbsp;13.13.2 BB-NCIPD BCG Vaccine for Tuberculosis (TB) Product Portfolios and Specifications &nbsp;13.13.3 BB-NCIPD BCG Vaccine for Tuberculosis (TB) Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.13.4 BB-NCIPD Main Business Overview &nbsp;13.13.5 BB-NCIPD Latest Developments &nbsp;13.14 Torlakinstitut &nbsp;13.14.1 Torlakinstitut Company Information &nbsp;13.14.2 Torlakinstitut BCG Vaccine for Tuberculosis (TB) Product Portfolios and Specifications &nbsp;13.14.3 Torlakinstitut BCG Vaccine for Tuberculosis (TB) Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.14.4 Torlakinstitut Main Business Overview &nbsp;13.14.5 Torlakinstitut Latest Developments &nbsp;13.15 IVAC�?�Institute�of�Vaccines�and�Medical�Biologicals &nbsp;13.15.1 IVAC�?�Institute�of�Vaccines�and�Medical�Biologicals Company Information &nbsp;13.15.2 IVAC�?�Institute�of�Vaccines�and�Medical�Biologicals BCG Vaccine for Tuberculosis (TB) Product Portfolios and Specifications &nbsp;13.15.3 IVAC�?�Institute�of�Vaccines�and�Medical�Biologicals BCG Vaccine for Tuberculosis (TB) Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.15.4 IVAC�?�Institute�of�Vaccines�and�Medical�Biologicals Main Business Overview &nbsp;13.15.5 IVAC�?�Institute�of�Vaccines�and�Medical�Biologicals Latest Developments &nbsp;13.16 Institut Pasteur de Tunis &nbsp;13.16.1 Institut Pasteur de Tunis Company Information &nbsp;13.16.2 Institut Pasteur de Tunis BCG Vaccine for Tuberculosis (TB) Product Portfolios and Specifications &nbsp;13.16.3 Institut Pasteur de Tunis BCG Vaccine for Tuberculosis (TB) Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.16.4 Institut Pasteur de Tunis Main Business Overview &nbsp;13.16.5 Institut Pasteur de Tunis Latest Developments 14 Research Findings and Conclusion

Report	Global BCG Vaccine for Tuberculosis (TB) Market Growth 2025-2031
Selected License	Single ID:LPI9824

Buyer Information

Order Summary